cbdMD, Inc. (YCBD)

ASE – Real vaqt narxi. Valyuta: USD

0.70

-0.01 (-1.12%)

Yopilishda: Jun 26, 2026, 3:59 PM EDT

0.70

+0.00 (0.70%)

Bozordan keyin: Jun 26, 2026, 7:32 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

cbdMD, Inc. (YCBD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

cbdMD, Inc. (YCBD)

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Videolar

No Data

Press-relizlar

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Search stocks

cbdMD, Inc. (YCBD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

cbdMD, Inc. (YCBD)

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Videolar

No Data

Press-relizlar

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026